Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-002923
Filing Date
2022-03-14
Accepted
2022-03-14 16:05:11
Documents
1
Period of Report
2022-03-10

Document Format Files

Seq Description Document Type Size
1 form4-03142022_040301.html 4  
1 form4-03142022_040301.xml 4 3346
  Complete submission text file 0001415889-22-002923.txt   4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Hurley Ariel (Reporting) CIK: 0001769740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 22736561